Trevi Therapeutics
TRVI
TRVI
137 hedge funds and large institutions have $554M invested in Trevi Therapeutics in 2025 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 53 increasing their positions, 32 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
66% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 32
25% more funds holding
Funds holding: 110 → 137 (+27)
2.2% more ownership
Funds ownership: 88.95% → 91.16% (+2.2%)
Holders
137
Holding in Top 10
8
Calls
$10.7M
Puts
$2.23M
Top Buyers
| 1 | +$20.9M | |
| 2 | +$18.8M | |
| 3 | +$15.8M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$11.1M |
| 5 |
BlackRock
New York
|
+$8.71M |
Top Sellers
| 1 | -$13M | |
| 2 | -$11.2M | |
| 3 | -$9.58M | |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
-$7.37M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$7.26M |
